首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1671833

外泌體市場按產品/服務、適應症、用途、製造服務、最終用途和地區分類

Exosomes Market, By Product & Service, By Indication, By Application, By Manufacturing Service, By End User, By Geography

出版日期: 2025年01月23日 | 出版商:

Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球外泌體市場規模估計為 2.221 億美元，預計 2032 年將達到 12.841 億美元，2025 年至 2032 年的年複合成長率(CAGR)為 28.5%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	2.221億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	28.50％	2032 年價值預測	12.841億美元

圖。

外泌體是奈米大小的細胞外囊泡，可作為細胞間信使，在細胞之間轉移蛋白質、脂質和遺傳物質。外泌體由多種類型的細胞自然釋放，並攜帶反映宿主細胞的特定生物分子。由於這種能力，外泌體已成為腫瘤學、神經病學和循環系統等各個應用領域的潛在診斷和治療工具。預計在預測期內，針對複雜疾病的基於外泌體的治療和診斷方法的日益普及將推動市場的成長。

市場動態：

全球外泌體市場的成長受到多種因素的推動，例如外泌體科學研究資金的增加、外泌體在疾病管理中的臨床應用的增加以及製藥公司對利用外泌體優勢的興趣日益濃厚。然而，外泌體分離和表徵技術方面的技術挑戰以及基於外泌體的程序相關的高成本等因素可能會抑制市場的成長。市場上還有機會可以幫助克服當前的挑戰，例如發現基於外泌體的新型療法以及使用外泌體進行藥物輸送。此外，人們對外泌體在疫苗開發中的應用越來越感興趣，這將在預測期內開闢新的途徑。

本研究的主要特點

本報告對全球外泌體市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。

全球外泌體市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行的分析。

研究涉及的主要企業包括賽默飛世爾科技公司 (Thermo Fisher Scientific, Inc.)、Bio-Techne、QIAGEN、Lonza、System Biosciences, LLC、Miltenyi Biotech、NX Pharmagen、Aethlon Medical, Inc.、Creative Medical Technologies Holdings, Inc.、Exopharm、RoosterBio, Inc.、丹納赫克、丹納赫。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球外泌體市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球外泌體市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 222.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	28.50%	2032 Value Projection:	USD 1,284.1 Mn

Exosomes are nano-sized extracellular vesicles that act as intercellular messengers by transferring proteins, lipids, and genetic materials between cells. They are released naturally by many cell types and carry specific biomolecules reflective of the host cells. Due to this ability, exosomes have emerged as potential diagnostic and therapeutic tools across various application areas such as oncology, neurology, and cardiology. The rising adoption of exosome-based therapies and diagnostics for complex diseases is expected to drive the market growth during the forecast period.

Market Dynamics:

The growth of the global exosomes market is driven by factors such as increasing research funding in exosome science, rising clinical applications of exosomes in disease management, and growing focus of pharmaceutical companies on harnessing exosome benefits. However, factors such as technical challenges in exosome isolation and characterization techniques as well as high costs associated with exosome-based procedures are likely to restrain the market growth. The market also presents opportunities in areas such as discovery of novel exosome-based therapies and use of exosomes for drug delivery that can help in overcoming some of the current challenges. Furthermore, growing interest in exosome applications in vaccine development will open up new avenues during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global exosomes market and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC, Miltenyi Biotech, NX Pharmagen, Aethlon Medical, Inc., Creative Medical Technologies Holdings, Inc., Exopharm, RoosterBio, Inc., Danaher Corporation, Everzom, Ciloa, and Unchained Labs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global exosomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes market

Market Segmentation

By Product & Service Insights (Revenue, USD Mn, 2020 - 2032)
- Kits & Reagents
- Antibodies
- Isolation, Purification, Quantitation Kits
- Other Kits & Reagents
- Instruments
- Services
By Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Cancer
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Other Diseases
By Application Insights (Revenue, USD Mn, 2020 - 2032)
- Biomarkers
- Vaccine Development
- Tissue Regeneration
- Drug Delivery
- Other Applications
By Manufacturing Service Insights (Revenue, USD Mn, 2020 - 2032)
- Stem Cell-Derived Exosome Manufacturing Services
- Dendritic Cell-Derived Exosome
- Others
By End User Insights (Revenue, USD Mn, 2020 - 2032)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinical Laboratories
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific, Inc.
- Bio-Techne
- QIAGEN
- Lonza
- System Biosciences, LLC
- Miltenyi Biotech
- NX Pharmagen
- Aethlon Medical, Inc.
- Creative Medical Technologies Holdings, Inc.
- Exopharm
- RoosterBio, Inc.
- Danaher Corporation
- Everzom
- Ciloa
- Unchained Labs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Exosomes Market, By Product & Service
- Global Exosomes Market, By Indication
- Global Exosomes Market, By Application
- Global Exosomes Market, By Manufacturing Service
- Global Exosomes Market, By End User
- Global Exosomes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Exosomes Market, By Product & Service, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Antibodies
Isolation, Purification, Quantitation Kits
Other Kits & Reagents
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exosomes Market, By Indication, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurodegenerative Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exosomes Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Tissue Regeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exosomes Market, By Manufacturing Service, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Stem Cell-Derived Exosome Manufacturing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Dendritic Cell-Derived Exosome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exosomes Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hospitals & Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exosomes Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Techne
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN
Lonza
System Biosciences, LLC
Miltenyi Biotech
NX Pharmagen
Aethlon Medical, Inc.
Creative Medical Technologies Holdings, Inc.
Exopharm
RoosterBio, Inc.
Danaher Corporation
Everzom
Ciloa
Unchained Labs